Drugs News and Research

RSS

Increasing physical activity over six years associated with decreased heart failure risk

By analyzing reported physical activity levels over time in more than 11,000 American adults, Johns Hopkins Medicine researchers conclude that increasing physical activity to recommended levels over as few as six years in middle age is associated with a significantly decreased risk of heart failure, a condition that affects an estimated 5 million to 6 million Americans.

15 May 2018

Scientists find overlap between causes of RA and Huntington’s disease

Using new analytic tools, researchers at University of California San Diego School of Medicine and the Icahn School of Medicine at Mount Sinai have decoded the epigenetic landscape for rheumatoid arthritis (RA), a common autoimmune disease that affects more than 1.3 million Americans.

15 May 2018

Scientists uncover new target for MRSA

Researchers at Michigan State University have identified why methicillin-resistant Staphylococcus aureus or MRSA is so resilient, a finding that could pave the way for potential new treatments.

15 May 2018

Researchers to explore how to prevent stress-related chronic pain conditions

More than 50 million people in the United States suffer from pain in the absence of injury. This includes patients with migraines, fibromyalgia, irritable bowel syndrome and many other disorders.

15 May 2018

Researchers to take 'unprecedented look' into protein behind hypertension, epilepsy, and overactive bladder

The seemingly unrelated conditions of hypertension, epilepsy and overactive bladder may be linked by electrical activity in a protein long studied by a biomedical engineer at Washington University in St. Louis.

15 May 2018

Researchers test new cancer research model that may reduce cost and speed up studies

A new model for improving how clinical trials are developed and conducted by bringing together academic cancer experts and pharmaceutical companies is being tested by research experts at The University of Texas MD Anderson Cancer Center.

15 May 2018

Researchers lab-test molecule that may combat common cold virus

Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.

15 May 2018

UTA bioengineering professor successfully patents new cancer trap

The University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts and kills circulating cancer cells that was invented by a faculty member. This cancer trap can be used for early diagnosis and treatment of metastasized cancer.

14 May 2018

Heart failure severity could vary based on the body's nitric oxide levels

The most common heart medications may get an assist from nitric oxide circulating in the body, according to a new study out of Case Western Reserve University School of Medicine.

14 May 2018

Scientists uncover genome variation linked to increased risk of developing Alzheimer's

An article published in Nature Medicine with the collaboration of the research group of Dr. Manel Esteller, director of the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute, ICREA Researcher and Professor of Genetics of the University of Barcelona, and Drs. Dave Monk and Isidre Ferrer, from the same center, shows that the inheritance of small changes in DNA alters the expression of the PM20D1 gene and is associated with an increased risk of developing Alzheimer's disease.

14 May 2018

Protein researchers identify several new potential targets for cancer

In a new study based on mouse cells internationally leading protein researchers have identified several new potential targets using state-of-the-art technology, many of which could be employed for future treatment of different types of cancers and diseases.

14 May 2018

Researchers use spheroids to screen for potential cancer drugs

Researchers from The Scripps Research Institute have reported a new and more effective way of screening for potential cancer drugs.

14 May 2018

First, marijuana. Are magic mushrooms next?

In Oregon and Denver, where marijuana is legal for recreational use, activists are now pushing toward a psychedelic frontier: "magic mushrooms."

14 May 2018

Research may pave way for new C. diff antitoxins and anti-cancer drugs

Researchers from the University of California, Irvine and Harvard University have discovered how the Clostridium difficile toxin B recognizes the human Frizzled protein, the receptor it uses to invade intestinal cells and lead to deadly gastrointestinal infections.

14 May 2018

Study gives insight into how signals enter cancer cells and drive aggressive growth

The outside of a cancer cell is bombarded by signals. They come from the immune system, supporting tissues and other structures. But how do those signals impact cancer?

14 May 2018

UCLA researchers identify receptor that plays key role in repairing damage caused by heart conditions

Studies have shown that a simple treatment called lipid emulsion therapy - fatty acids administered intravenously - can heal damage to the heart after a heart attack or cardiac arrest. But researchers haven't understood exactly how the treatment works or whether there are more effective ways to repair the heart.

14 May 2018

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

Researchers screen molecules that could be potential target for prostate cancer treatments

Cancer researchers at the University of Bath have measured systematically how efficient molecules are at suppressing the activity of a protein associated with prostate and other cancers. The molecules could eventually be developed into new anti-cancer drugs.

14 May 2018

Adding chemotherapy to treatment regimen can give children with PVS a chance to grow up

Pulmonary vein stenosis (PVS) is a rare disease in which abnormal cells build up inside the veins responsible for carrying oxygen-rich blood from the lungs to the heart. It restricts blood flow through these vessels, eventually sealing them off entirely if left untreated.

11 May 2018

Trump vows (again) to lower drug prices but skeptics doubt much will change

President Donald Trump, armed with the expertise of staff seasoned in the ways of the drug industry, unveiled his blueprint to address sky-high drug prices Friday afternoon, promising that increasing industry competition will help Americans save at the pharmacy counter.

11 May 2018

Drugs News and Research

Increasing physical activity over six years associated with decreased heart failure risk

Scientists find overlap between causes of RA and Huntington’s disease

Scientists uncover new target for MRSA

Researchers to explore how to prevent stress-related chronic pain conditions

Researchers to take 'unprecedented look' into protein behind hypertension, epilepsy, and overactive bladder

Researchers test new cancer research model that may reduce cost and speed up studies

Researchers lab-test molecule that may combat common cold virus

UTA bioengineering professor successfully patents new cancer trap

Heart failure severity could vary based on the body's nitric oxide levels

Scientists uncover genome variation linked to increased risk of developing Alzheimer's

Protein researchers identify several new potential targets for cancer

Researchers use spheroids to screen for potential cancer drugs

First, marijuana. Are magic mushrooms next?

Research may pave way for new C. diff antitoxins and anti-cancer drugs

Study gives insight into how signals enter cancer cells and drive aggressive growth

UCLA researchers identify receptor that plays key role in repairing damage caused by heart conditions

FDA approves new drug to treat MS in pediatric patients

Researchers screen molecules that could be potential target for prostate cancer treatments

Adding chemotherapy to treatment regimen can give children with PVS a chance to grow up

Trump vows (again) to lower drug prices but skeptics doubt much will change

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News